课题基金 / 基金详情

项目摘要

项目成果

Henry J. Pownall的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
This subproject is one of many research subprojects utilizing the resources provided by a Center grant funded by NIH/NCRR. The subproject and investigator (PI) may have received primary funding from another NIH source, and thus could be represented in other CRISP entries. The institution listed is for the Center, which is not necessarily the institution for the investigator. Human plasma high-density lipoproteins (HDL), the primary vehicle for reverse cholesterol transport, are the target of serum opacity factor (SOF), a virulence determinant of Streptococcus pyogenes that turns serum opaque. HDL comprises a core of neutral lipids, cholesteryl esters and some triglycerides, surrounded by a surface monolayer of cholesterol, phospholipids, and specialized proteins [apolipoproteins (apos) A-I and A-II]. A HDL is an unstable particle residing in a kinetic trap from which it can escape via chaotropic, detergent, or thermal perturbation. Recombinant (r) SOF catalyzes the transfer of nearly all neutral lipids of ?100,000 HDL particles (D ? 8.5 nm) into a single, large cholesteryl ester-rich microemulsion (CERM; D > 100 nm), leaving a new HDL-like particle [neo HDL (D ? 5.8 nm)] while releasing lipid-free (LF) apo A-I. CERM formation and apo A-I release have similar kinetics, suggesting parallel or rapid consecutive steps.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Atheroprotection via Reduced Plasma High Density Lipoprotein-Free Cholesterol Bioavailability
Atheroprotection via Reduced Plasma High Density Lipoprotein-Free Cholesterol Bioavailability
Atheroprotection via Reduced Plasma High Density Lipoprotein-Free Cholesterol Bioavailability
High Density Lipoprotein Biogenesis and Speciation
海外基金